State of Wisconsin Investment Board
EGRX

State of Wisconsin Investment Board’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

State of Wisconsin Investment Board’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,500
Closed -$112K – 2470
2023
Q4 		$112K Buy
21,500
+8,700
+68% +$85.9K ﹤0.01% 2264
2023
Q3 		$202K Sell
12,800
-11,030
-46% -$198K ﹤0.01% 2242
2023
Q2 		$463K Buy
23,830
+1,450
+6% +$34.4K ﹤0.01% 1853
2023
Q1 		$635K Sell
22,380
-10,012
-31% -$297K ﹤0.01% 1745
2022
Q4 		$947K Buy
32,392
+17,681
+120% +$562K ﹤0.01% 1522
2022
Q3 		$389K Buy
14,711
+2,808
+24% +$103K ﹤0.01% 2092
2022
Q2 		$529K Sell
11,903
-2,097
-15% -$96.3K ﹤0.01% 2052
2022
Q1 		$693K Hold
14,000
– – ﹤0.01% 1723
2021
Q4 		$713K Hold
14,000
– – ﹤0.01% 1556
2021
Q3 		$781K Hold
14,000
– – ﹤0.01% 1524
2021
Q2 		$599K Hold
14,000
– – ﹤0.01% 1634
2021
Q1 		$584K Sell
14,000
-1,600
-10% -$74.3K ﹤0.01% 1546
2020
Q4 		$726K Sell
15,600
-1,900
-11% -$88.9K ﹤0.01% 1418
2020
Q3 		$743K Buy
17,500
+3,400
+24% +$149K ﹤0.01% 1365
2020
Q2 		$677K Hold
14,100
– – ﹤0.01% 1337
2020
Q1 		$649K Sell
14,100
-300
-2% -$15.1K ﹤0.01% 1281
2019
Q4 		$865K Hold
14,400
– – ﹤0.01% 1281
2019
Q3 		$815K Hold
14,400
– – ﹤0.01% 1183
2019
Q2 		$802K Buy
14,400
+300
+2% +$15.6K ﹤0.01% 1192
2019
Q1 		$712K Buy
14,100
+3,200
+29% +$142K ﹤0.01% 1246
2018
Q4 		$439K Buy
10,900
+300
+3% +$15.5K ﹤0.01% 1351
2018
Q3 		$735K Hold
10,600
– – ﹤0.01% 1301
2018
Q2 		$802K Buy
10,600
+4,600
+77% +$289K ﹤0.01% 1244
2018
Q1 		$316K Hold
6,000
– – ﹤0.01% 1357
2017
Q4 		$321K Hold
6,000
– – ﹤0.01% 1354
2017
Q3 		$358K Hold
6,000
– – ﹤0.01% 1355
2017
Q2 		$473K Buy
+6,000
New +$491K ﹤0.01% 1296

Other funds holding EGRX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return

State of Wisconsin Investment Board's EGRX Position: Q1 2024 in Review

State of Wisconsin Investment Board sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2024, closing a stake of 21,500 shares — an estimated $112K sold.

State of Wisconsin Investment Board first reported a position in EGRX in Q2 2017 and held it in 27 quarters. The position peaked at $947K in Q4 2022. 91 funds tracked by Wall St. Rank hold EGRX as of Q1 2024.

  • State of Wisconsin Investment Board reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 21,500 Eagle Pharmaceuticals, Inc. shares in Q1 2024, an estimated $112K.
  • State of Wisconsin Investment Board first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2017 and held it in 27 quarters.
  • State of Wisconsin Investment Board's Eagle Pharmaceuticals, Inc. position peaked at $947K in Q4 2022.
  • 91 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2024, filed 14 May 2024.